ONCO vs ZTS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 21, 2026

ONCO

43.8
AI Score
VS
ONCO Wins

ZTS

38.9
AI Score

Investment Advisor Scores

ONCO

44score
Recommendation
HOLD

ZTS

39score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric ONCO ZTS Winner
Forward P/E 0 11.9617 Tie
PEG Ratio 0 6.6443 Tie
Revenue Growth -83.9% -0.2% ZTS
Earnings Growth 0.0% 1.2% ZTS
Tradestie Score 43.8/100 38.9/100 ONCO
Profit Margin 0.0% 27.7% ZTS
Beta 1.00 1.00 Tie
AI Recommendation HOLD SELL ONCO

Relative Price Performance (Last 90 Days)

ONCO 1M: -1.8% · 3M: -31.0% ZTS 1M: -4.9% · 3M: -6.0%

Current Technical Phase

ONCO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -14.1%), weak momentum, RSI 44

RSI (14): 43.6 · Price: $0.65

ZTS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -0.9%), weak momentum, RSI 36

RSI (14): 36.3 · Price: $71.33

Fundamentals Snapshot

Metric ONCO ZTS
Market Cap
Forward P/E 0.0 10.9
Trailing P/E 0.0 11.6
Revenue (TTM)
Revenue Growth -0.8% 0.0%
Gross Margin 0.8% 0.7%
Operating Margin -131.1% 0.4%
EPS 749.08 6.13
Dividend Yield 0.03%

Frequently Asked Questions

Based on our detailed analysis, ONCO is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.